• Users Online: 932
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Contacts Login

  Reader Comments

Year : 2021 | Volume:  34 | Issue Number:  2

SELECTED SUMMARY

Short-duration adjuvant trastuzumab therapy in human epidermal growth factor receptor 2-positive breast cancers: Has its time come?

Gogia Ajay, Mittal Abhenil, Sharma Atul, Sagiraju Hari Krishna Raju

Add Your Comments
 
No one has added comments on this article. Click here to add your remarks


 

Back To Article
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Ted Talks / Other Talks